ENहिन्दी soon

GLP‑1 medicines and prices in India

Every GLP‑1 medicine sold in India, at every dose: the price of a pack, and what that comes to a month and a year.

Prices here are MRPs: the maximum retail price the maker prints on the pack, including GST. We take the MRP from the maker's own statement first, then a dated news report, then the price regulator (NPPA), and last from at least two pharmacy listings that show the same MRP. Never a discount price. Health insurance in India usually doesn't pay for these medicines.1,2

Before you go further. These are prescription-only medicines. A government statement of 1 April 2026 said only endocrinologists, internal-medicine specialists and cardiologists can prescribe them.3 CDSCO expert-committee minutes attach a similar condition to some approvals (endocrinologist or internal-medicine specialist), but we found no rule covering every brand.4,5 They have real risks: read Side effects and risks first. A lower price doesn't make a medicine right for you.

How much do Wegovy, Ozempic and Mounjaro cost in India?

Every GLP‑1 medicine sold in India, by dose. Prices checked 11 Oct 2026.
Dose and packPer packPer monthPer year
DulaglutideAbout dulaglutide →
TrulicityType 2 diabetes onlyEli Lilly · Weekly injection, single-dose pensApproved for: Type 2 diabetes6
0.75 mg2 packs of 2 pens at ₹5,669.06 each₹11,3387₹12,283₹1,47,394
1.5 mg2 packs of 2 pens at ₹5,669.06 each₹11,3387₹12,283₹1,47,394
LiraglutideAbout liraglutide →
LirafitType 2 diabetes onlyGlenmark · Daily injectionApproved for: Type 2 diabetes8
0.6 mgPen MRP ₹2,085.94. 1 pen of 18 mg in 30 days at this dose (pen MRP x 1)₹2,0869₹2,109₹25,310
1.2 mgPen MRP ₹2,085.94. 2 pens of 18 mg in 30 days at this dose (pen MRP x 2)₹4,1729₹4,218₹50,620
1.8 mgPen MRP ₹2,085.94. 3 pens of 18 mg in 30 days at this dose (pen MRP x 3)₹6,2589₹6,328₹75,930

MRP as listed by two pharmacies in October 2026: ₹2,085.94 a pen, about ₹139 a day at 1.2 mg. Glenmark's January 2024 launch figure was about ₹100 a day at 1.2 mg.8,9
VictozaType 2 diabetes onlyNovo Nordisk (some pharmacies now list Abbott India as marketer) · Daily injection, 3 mL penApproved for: Type 2 diabetes8
0.6 mgPen MRP ₹4,991.25. 1 pen of 18 mg in 30 days at this dose (pen MRP x 1)₹4,99110₹5,046₹60,557
1.2 mgPen MRP ₹4,991.25. 2 pens of 18 mg in 30 days at this dose (pen MRP x 2)₹9,98310₹10,094₹1,21,127
1.8 mgPen MRP ₹4,991.25. 3 pens of 18 mg in 30 days at this dose (pen MRP x 3)₹14,97410₹15,140₹1,81,685

MRP as listed by three pharmacies in October 2026: ₹4,991.25 a pen. One shows the old MRP of ₹5,324; the drop matches the GST cut on medicines from 12% to 5% on 22 September 2025.10,11
SemaglutideAbout semaglutide →
Generic semaglutide pens (40+ brands)Many Indian companies (40+ brands) · Weekly injection, penApproved for: Varies by brand: some type 2 diabetes only, some diabetes and weight12,13
Starting doses in pens, makers' launch prices, March 2026Pen of 4 weekly doses; price range across makers₹1,800–4,20012,13,14,15₹1,950–4,550₹23,400–54,600
Top doses where the maker published one, March 2026Pen of 4 weekly doses; price range across makers₹4,200–8,00014,16,17₹4,550–8,667₹54,600–1,04,000

Pens only. Most makers published one launch price, mostly for starting doses. Higher doses cost more where makers published them (see the top-dose range). Natco's vials are priced separately: from ₹1,290 a month (lower strengths) to about ₹1,750 (top strength). Prices may have changed since launch.12,13,14,15
OzempicType 2 diabetes onlyNovo Nordisk · Weekly injection, penApproved for: Type 2 diabetes18,19
0.25 mgPrice reported per month, 4 weekly doses₹5,66018₹6,132₹73,580
0.5 mg1 pen = 4 weekly doses. Pharmacy-listed MRP (2 listings agree)₹8,10020₹8,775₹1,05,300
1 mgPrice reported per month, 4 weekly doses₹9,10018₹9,858₹1,18,300
PoviztraNovo Nordisk (sold in India by Emcure) · Weekly injection, penApproved for: Obesity and weight management21
0.25 mgPrice reported per month, 4 weekly doses₹3,99921₹4,332₹51,987
0.5 mgPrice reported per month, 4 weekly doses₹4,99922₹5,416₹64,987
1 mgPrice reported per month, 4 weekly doses₹5,99922₹6,499₹77,987
1.7 mgPrice reported per month, 4 weekly doses₹7,99922₹8,666₹1,03,987
2.4 mgPrice reported per month, 4 weekly doses₹8,99921₹9,749₹1,16,987
RybelsusType 2 diabetes onlyNovo Nordisk · Daily tabletApproved for: Type 2 diabetes23
3 mg30 days; pharmacy listings differ₹8,916–9,51024₹9,015–9,616₹1,08,181–1,15,388
7 mgStrip of 10 at ₹3,300; 30 tablets = 3 strips₹9,90024₹10,010₹1,20,120
14 mgStrip of 10 at ₹3,628; 30 tablets = 3 strips₹10,88424₹11,005₹1,32,059
WegovyNovo Nordisk · Weekly injection, penApproved for: Obesity and weight management; Teens 12 and older above 60 kg (May 2026); Fatty liver with scarring (MASH), adults (July 2026)18,25,26
0.25 mg1 pen = 4 weekly doses₹5,66018₹6,132₹73,580
0.5 mg1 pen = 4 weekly doses (maker's weekly price x 4)₹8,10027₹8,775₹1,05,300
1 mg1 pen = 4 weekly doses (maker's weekly price x 4)₹9,10027₹9,858₹1,18,300
1.7 mg1 pen = 4 weekly doses₹12,75028,29₹13,813₹1,65,750
2.4 mg1 pen = 4 weekly doses₹16,40018₹17,767₹2,13,200
TirzepatideAbout tirzepatide →
MounjaroEli Lilly · Weekly injection, KwikPen (4 doses)Approved for: Type 2 diabetes; Obesity30,31
2.5 mg1 KwikPen = 4 weekly doses. Pharmacy-listed MRP (2 listings agree)₹13,12532₹14,219₹1,70,625
5 mg1 KwikPen = 4 weekly doses. Pharmacy-listed MRP (2 listings agree)₹16,40632₹17,773₹2,13,278
7.5 mg1 KwikPen = 4 weekly doses. Pharmacy-listed MRP (2 listings agree)₹20,62532₹22,344₹2,68,125
10 mg1 KwikPen = 4 weekly doses. Pharmacy-listed MRP (2 listings agree)₹20,62532₹22,344₹2,68,125
12.5 mg1 KwikPen = 4 weekly doses. Pharmacy-listed MRP (2 listings agree)₹25,78132₹27,929₹3,35,153
15 mg1 KwikPen = 4 weekly doses. Pharmacy-listed MRP (2 listings agree)₹25,78132₹27,929₹3,35,153

MRPs as listed by two pharmacies in October 2026. They equal Lilly's August 2025 launch MRPs (₹14,000 to ₹27,500) less the GST cut on medicines from 12% to 5% on 22 September 2025, which the price regulator told makers to pass on (₹14,000 x 105/112 = ₹13,125). Lilly has not published the new figures.11,30,32,33
Mounjaro (single-dose vials)Eli Lilly · Weekly injection, single-dose vial (1 dose)Approved for: Type 2 diabetes; Obesity30,31
2.5 mg4 single-dose vials = 4 weekly doses; MRP ₹3,281 a vial (₹3,281.25). Pharmacy-listed MRP (3 listings agree)₹13,12534₹14,219₹1,70,625
5 mg4 single-dose vials = 4 weekly doses; MRP ₹4,102 a vial (₹4,101.56). Pharmacy-listed MRP (2 listings agree)₹16,40634₹17,773₹2,13,278

Vials are priced per single dose: 2.5 mg ₹3,281, 5 mg ₹4,102, as listed by pharmacies in October 2026. Four vials cost the same as one KwikPen of the same strength. Launch MRPs (March 2025) were ₹3,500 and ₹4,375; the listed MRPs equal these less the GST cut from 12% to 5% on 22 September 2025 (x 105/112). Lilly has not published the new figures. Vials are listed at 2.5 and 5 mg only.11,33,34,35
YurpeakEli Lilly (sold in India by Cipla) · Weekly injectionApproved for: Type 2 diabetes; Chronic weight management31
2.5 mg4 weekly doses; pharmacy listings differNot published No figure published. Cipla said the price will be the same as Mounjaro.
5 mg4 weekly doses; pharmacy listings differNot published No figure published.
7.5 mg4 weekly doses; pharmacy listings differNot published No figure published.
10 mg4 weekly doses; pharmacy listings differNot published No figure published.
12.5 mg4 weekly doses; pharmacy listings differNot published No figure published.
15 mg4 weekly doses; pharmacy listings differNot published No figure published.

No MRP published. Cipla said "the price will be the same as Mounjaro" but gave no figure.31

Per month and per year. A year is 52 weeks: 52 weekly doses, or 364 days of a daily medicine. We work out the cost of one dose (or one day) from the pack, multiply it by 52 (or 364) for the year, and divide the year by 12 for a month. So a month of a weekly pen costs a little more than one pen of 4 doses: a year takes 13 pens, not 12. This is the method our cost calculator uses. Rounded to the nearest rupee.

Grouped by medicine, in alphabetical order. Not sorted by price, and not a recommendation. We don't list or link pharmacies, clinics or online sellers. Your prescriber sets the medicine and the dose.

How we get these prices

MRP only (the maker's printed list price). Pharmacy selling or discounted prices are never used. A dose with no MRP at any of the four levels below is null and shown as 'Not published'.

  1. Maker: the company's own price statement or press release
  2. News report naming the maker's price
  3. NPPA (government price regulator) notice
  4. MRP printed on at least 2 agreeing pharmacy listings

We count a year as 52 weekly doses, so a month is about 4.3 doses.

Prices checked
11 Oct 2026
Next check
November 2026

How we write and check prices · Cost calculator

More on prices and paying

Cost calculatorAdd up a plan over months, with the dose steps. InsuranceHow people pay in India. CompareMedicines side by side. Open data: all countriesEvery price table as a CSV file.
The medicines themselves What it is, how it works, results and side effects (any country).
DulaglutideLiraglutideSemaglutideTirzepatide

Use this table

Download this table (CSV)

40 rows, one per dose. UTF‑8, opens in Excel. Free to reuse under CC BY 4.0: cite GLP Guidebook with the page URL. Open data: all countries

How to cite

GLP Guidebook. GLP-1 medicines and prices in India. https://glpguidebook.com/in/medicines/ (prices checked 11 Oct 2026). Licence: CC BY 4.0.

Questions people ask

How much does Wegovy cost in India?

The MRP of Wegovy is ₹5,660 at 0.25 mg, ₹8,100 at 0.5 mg, ₹9,100 at 1 mg, ₹12,750 at 1.7 mg and ₹16,400 at 2.4 mg, for a pack of 4 weekly doses. That comes to about ₹73,580–2,13,200 a year.18,27,28,29

How much does Mounjaro cost in India?

The MRP of Mounjaro is ₹13,125 at 2.5 mg, ₹16,406 at 5 mg, ₹20,625 at 7.5 and 10 mg and ₹25,781 at 12.5 and 15 mg, for a pack of 4 weekly doses. That comes to about ₹1,70,625–3,35,153 a year.32

Does health insurance pay for these medicines in India?

Usually not covered. Standard health insurance in India pays when you are admitted to hospital; an OPD add-on may cover some medicines and tests.1,2 Many policies also exclude obesity and weight-control treatment.2

Which of these medicines are for type 2 diabetes only?

Trulicity, Lirafit, Victoza, Ozempic and Rybelsus are approved in India for type 2 diabetes only, and the table labels them "Type 2 diabetes only".6,8,18,19,23 Some contain the same medicine as a brand approved for weight (Ozempic and Wegovy are both semaglutide), but the approved uses, doses and price differ.

Why is a year 13 pens and not 12?

A weekly pen holds 4 doses, so it lasts 4 weeks. A year is 52 weeks, so it takes 13 pens, and a month (a twelfth of the year) costs a little more than one pen. For daily medicines we count 364 days. This is how our cost calculator counts.

Why don't you show the cheapest price or pharmacy prices?

We show MRPs from the maker, news reports, the price regulator or matching pharmacy listings only. Sellers' prices change often and differ from shop to shop, and listing them would turn a guide into a shopping list. That's why the table is grouped by medicine, never sorted by price, and names no pharmacy, clinic or online seller. How we show prices.

Sources

  1. Niva Bupa. Health insurance exclusion list updated from IRDAI (standard cover pays for hospital admission; OPD is an add-on). 5 Oct 2026. Link
  2. Bajaj General Insurance. Health insurance policy general exclusions (Excl 06, obesity and weight control). 5 Oct 2026. Link
  3. Press Information Bureau (PIB Research), "GLP-1 Drugs: Use, Risks, and Regulation" ("In India, GLP-1 drugs can only be prescribed by endocrinologists, internal medicine specialists, and cardiologists"), 1 April 2026. PDF. Also reported by Outlook India, 1 April 2026.
  4. CDSCO, Subject Expert Committee (Endocrinology & Metabolism), recommendations of 20–21 April 2023, tirzepatide ("The drug should be sold by retail under prescription of Endocrinologist or internal medicine specialists only"). PDF · Archived copy
  5. CDSCO, Subject Expert Committee (Endocrinology & Metabolism), recommendations of 13–14 February 2024, semaglutide (approved warning: "To be sold by retail on the prescription of an Endocrinologist, and Internal medicine"). PDF · Archived copy
  6. BioSpectrum. Once-a-week drug for type 2 diabetes launched by Lilly India (Trulicity). 3 Mar 2016. Link
  7. Pharmacy listings showing the MRP printed on the pack (at least two agree). Sellers are not named or linked. Checked 5 Oct 2026.
  8. Business Standard. Glenmark cuts diabetes drug cost by 70% with first Indian biosimilar launch (Lirafit, about ₹100 for a 1.2 mg daily dose). 3 Jan 2024. Link
  9. Pharmacy listings showing the MRP printed on the pack (at least two agree). Sellers are not named or linked. Checked 5 Oct 2026.
  10. Pharmacy listings showing the MRP printed on the pack (at least two agree). Sellers are not named or linked. Checked 5 Oct 2026.
  11. Press Information Bureau (Ministry of Finance). Recommendations of the 56th meeting of the GST Council: "Reduction of GST on all other drugs and medicines from 12% to 5%"; changes on goods "implemented with effect from 22 September 2025". Link
  12. Pearce IP. Generic semaglutide launches in India, including by Dr Reddy's, Zydus, Alkem, Sun Pharma and Glenmark. 21 Mar 2026. Link
  13. Alkem Laboratories. Press release: semaglutide launch, pre-filled disposable pen of four doses "at an affordable price starting INR 1,800"; DCGI approval for type 2 diabetes and weight management. 21 Mar 2026. Link
  14. Dr Reddy's Laboratories. Press release (filed with the US SEC): launch of Obeda (semaglutide) for type 2 diabetes, 2 mg and 4 mg pens, each "a minimum of 4 weekly doses"; "INR 4,200 per month for both the strengths". 21 Mar 2026. Link
  15. Torrent Pharmaceuticals. Press release: oral and injectable semaglutide (Sembolic, Semalix), injectable from ₹3,999 a month. 21 Mar 2026. Link
  16. Sun Pharma. Press release: Sun Pharma launches its semaglutide injection under the brand names Noveltreat and Sematrinity in India. Noveltreat (weight, 0.25 to 2.4 mg): "weekly therapy costs, from initiation to the highest dose, range from approximately ₹900 to ₹2,000". 21 Mar 2026. Link
  17. Medical Dialogues. Recalls by Dr Reddy's, Torrent put spotlight on quality standards in India's semaglutide market (generic "monthly therapy now ranging from around Rs 1,290 to Rs 8,000"). 10 Jul 2026. Link
  18. Business Standard. As generics wave builds up, Novo Nordisk slashes Ozempic, Wegovy prices. 31 Mar 2026. Link
  19. Business Standard. Novo Nordisk launches Ozempic in India at ₹2,200/week (type 2 diabetes). 12 Dec 2025. Link
  20. Pharmacy listings showing the MRP printed on the pack (at least two agree). Sellers are not named or linked. Checked 5 Oct 2026.
  21. Medical Dialogues. Emcure cuts Poviztra price by 55%, starting dose now ₹3,999 per month. 4 Apr 2026. Link
  22. Indian Pharma Post (IPP Bureau). Emcure Pharma reduces Poviztra starting dose price by 55% in India (revised monthly MRPs, inclusive of taxes, effective 3 Apr 2026). Link
  23. Medical Dialogues. Novo Nordisk gets CDSCO panel nod for Rybelsus label update (3, 7 and 14 mg tablets, type 2 diabetes). 10 Sep 2025. Link
  24. Pharmacy listings showing the MRP printed on the pack (at least two agree). Sellers are not named or linked. Checked 5 Oct 2026.
  25. IndiaMedToday. Wegovy gets CDSCO nod for adolescent obesity (12 and older, above 60 kg). 29 May 2026. Link
  26. Business Standard. Wegovy gets CDSCO nod for fatty liver disease (non-cirrhotic MASH with moderate-to-advanced fibrosis). 17 Jul 2026. Link
  27. ThePrint (Reuters). Novo Nordisk again cuts Ozempic, Wegovy prices by up to 48% in India as generics flood market: weekly price 0.25 mg ₹1,415; Wegovy 0.5 mg ₹2,025; 1 mg ₹2,275 ("Novo Nordisk said in a statement"). 1 Apr 2026. Link
  28. Pharmacy listings showing the MRP printed on the pack (at least two agree). Sellers are not named or linked. Checked 1 Oct 2026.
  29. Pharmacy listings showing the MRP printed on the pack (at least two agree). Sellers are not named or linked. Checked 5 Oct 2026.
  30. Business Standard. Mounjaro KwikPen by Lilly debuts in India at ₹14,000 for diabetes, obesity (launch MRPs for each strength, one-month supply). 13 Aug 2025. Link
  31. Cipla. Cipla launches Yurpeak (tirzepatide): "Lilly will manufacture and supply Yurpeak to Cipla, and the price will be the same as Mounjaro". 10 Dec 2025. Link
  32. Pharmacy listings showing the MRP printed on the pack (at least two agree). Sellers are not named or linked. Checked 5 Oct 2026.
  33. NPPA. Office memorandum F. No. 12(24)/2021/DP/NPPA/Div.II(Vol.II)-Part(1), 13 Sep 2025, revising the OM of 12 Sep 2025: makers to issue revised price lists "reflecting the revised GST rates and Revised MRP" from 22 Sep 2025. Link
  34. Pharmacy listings showing the MRP printed on the pack (at least two agree). Sellers are not named or linked. Checked 5 Oct 2026.
  35. Business Standard. Eli Lilly launches Mounjaro in India in a single-dose vial: "priced at Rs 3,500 for a 2.5 mg vial and Rs 4,375 for a 5 mg vial" (launch MRPs, before the GST cut). 20 Mar 2025. Link